Commonwealth Retirement Investments LLC Makes New Investment in VanEck Biotech ETF (NASDAQ:BBH)

Commonwealth Retirement Investments LLC acquired a new stake in VanEck Biotech ETF (NASDAQ:BBH) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,372 shares of the company’s stock, valued at approximately $215,000. Commonwealth Retirement Investments LLC owned approximately 0.06% of VanEck Biotech ETF as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the business. Truvestments Capital LLC bought a new stake in VanEck Biotech ETF during the 3rd quarter valued at approximately $44,000. FSA Wealth Management LLC purchased a new stake in VanEck Biotech ETF during the 3rd quarter valued at approximately $54,000. Coastline Trust Co bought a new stake in shares of VanEck Biotech ETF during the third quarter valued at approximately $59,000. Wilmington Savings Fund Society FSB purchased a new position in shares of VanEck Biotech ETF in the third quarter worth $166,000. Finally, Tyler Stone Wealth Management boosted its position in shares of VanEck Biotech ETF by 79.5% during the third quarter. Tyler Stone Wealth Management now owns 1,472 shares of the company’s stock worth $261,000 after acquiring an additional 652 shares during the last quarter. Institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Up 0.4 %

BBH opened at $166.16 on Tuesday. The company has a fifty day moving average of $161.19 and a 200 day moving average of $169.28. VanEck Biotech ETF has a fifty-two week low of $151.35 and a fifty-two week high of $183.64.

VanEck Biotech ETF Dividend Announcement

The company also recently disclosed a dividend, which was paid on Tuesday, December 24th. Stockholders of record on Monday, December 23rd were given a dividend of $1.2517 per share. The ex-dividend date was Monday, December 23rd.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.